This activity is supported by GSK and Pfizer
Most people see real change by the end of the loading phase
Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP: Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse
These compounds are considered important antioxidants that may play a key role in tissue repair by protecting cells from oxidative damage
Heres how it works: Mechanism of Action GLP-1 Receptor Agonism: Like other GLP-1 receptor agonists, Tirzepatide enhances insulin secretion in response to meals, suppresses glucagon release (which decreases glucose production by the liver), slows gastric emptying, and promotes satiety, which can lead to reduced food intake and weight loss
The honest comparison is about dose, time, what else you want in the bag, and how often you plan to come in